Sean Richard Dinn

Title: Innovations of Sean Richard Dinn

Introduction

Sean Richard Dinn is a notable inventor based in Delmar, NY (US). He holds a total of 10 patents, showcasing his significant contributions to the field of innovation. His work primarily focuses on advancements in imaging agents and methods related to peroxidases.

Latest Patents

One of his latest patents is for alpha-fluoroalkyl dihydrotetrabenazine imaging agents and probes. This invention provides novel alpha-fluoroalkyl dihydrotetrabenazine compounds that are believed to possess high affinity for VMAT-2, a biomarker implicated in human diabetes. The compounds are useful as PET imaging agents targeting the VMAT-2 biomarker and are provided in both racemic and enantiomerically enriched forms. Another significant patent involves heme choline esters and methods of activating an apo-peroxidase. This method includes hydrolyzing the heme choline ester with a choline esterase and converting the apo-peroxidase to active peroxidase. The methods also allow for the detection of analytes in samples, providing a comprehensive approach to diagnostics.

Career Highlights

Throughout his career, Sean Richard Dinn has worked with prominent companies, including General Electric Company. His innovative work has led to advancements in various scientific fields, particularly in medical imaging and biochemical methods.

Collaborations

Sean has collaborated with notable individuals such as Michael James Rishel and Bruce Fletcher Johnson. These collaborations have contributed to the development of his patents and innovations.

Conclusion

Sean Richard Dinn's contributions to the field of innovation are significant, particularly in the areas of imaging agents and biochemical methods. His work continues to impact the scientific community and advance medical technology.